Cronos Group (TSXV:MJN) announced their subsidiary Peace Naturals Project was granted a Dealer’s License pursuant to the Controlled Drugs and Substances Act.
As quoted in the press release:
This enables the Company to, through Peace, export medical cannabis extracts, including concentrated oil and resin products, internationally.
“Cronos is focused on having a presence in all major international markets as the regulatory environment evolves. This Dealer’s License will enable us to expand the product offerings we export to these jurisdictions, which is instrumental to our global expansion strategy,” said Mike Gorenstein, CEO of Cronos.